Chart GTG, page-118

I agree, GTG will be guided by GENE this week."Very good buying at 4.1c IMO. I would not be surprised if we get an update soon on the brevagen plus roll out from the Jan ann.

6 new breast diagnosis/treatment centres are expected to begin offering BREVAGenplus® to their at-risk patients in a systematic broad fashion in the January to March timeframe, with a growing number of additional new breast and imaging centre customers expected to follow later in calendar year 2015. As a result, the Company expects sales growth to accelerate in the second half 2015 and beyond.

Patience, as always, is the key.

All In My Own Opinion

Cheers
B​